These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 22865388)

  • 1. Pharmacological inhibition of soluble epoxide hydrolase provides cardioprotection in hyperglycemic rats.
    Guglielmino K; Jackson K; Harris TR; Vu V; Dong H; Dutrow G; Evans JE; Graham J; Cummings BP; Havel PJ; Chiamvimonvat N; Despa S; Hammock BD; Despa F
    Am J Physiol Heart Circ Physiol; 2012 Oct; 303(7):H853-62. PubMed ID: 22865388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble epoxide hydrolase inhibition improves coronary endothelial function and prevents the development of cardiac alterations in obese insulin-resistant mice.
    Roche C; Besnier M; Cassel R; Harouki N; Coquerel D; Guerrot D; Nicol L; Loizon E; Remy-Jouet I; Morisseau C; Mulder P; Ouvrard-Pascaud A; Madec AM; Richard V; Bellien J
    Am J Physiol Heart Circ Physiol; 2015 May; 308(9):H1020-9. PubMed ID: 25724490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble epoxide hydrolase inhibition and gene deletion are protective against myocardial ischemia-reperfusion injury in vivo.
    Motoki A; Merkel MJ; Packwood WH; Cao Z; Liu L; Iliff J; Alkayed NJ; Van Winkle DM
    Am J Physiol Heart Circ Physiol; 2008 Nov; 295(5):H2128-34. PubMed ID: 18835921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardioprotection by controlling hyperamylinemia in a "humanized" diabetic rat model.
    Despa S; Sharma S; Harris TR; Dong H; Li N; Chiamvimonvat N; Taegtmeyer H; Margulies KB; Hammock BD; Despa F
    J Am Heart Assoc; 2014 Aug; 3(4):. PubMed ID: 25146704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased myocardial SERCA expression in early type 2 diabetes mellitus is insulin dependent: In vivo and in vitro data.
    Fredersdorf S; Thumann C; Zimmermann WH; Vetter R; Graf T; Luchner A; Riegger GA; Schunkert H; Eschenhagen T; Weil J
    Cardiovasc Diabetol; 2012 May; 11():57. PubMed ID: 22621761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Redox-Resistant SERCA [Sarco(endo)plasmic Reticulum Calcium ATPase] Attenuates Oxidant-Stimulated Mitochondrial Calcium and Apoptosis in Cardiac Myocytes and Pressure Overload-Induced Myocardial Failure in Mice.
    Goodman JB; Qin F; Morgan RJ; Chambers JM; Croteau D; Siwik DA; Hobai I; Panagia M; Luptak I; Bachschmid M; Tong X; Pimentel DR; Cohen RA; Colucci WS
    Circulation; 2020 Dec; 142(25):2459-2469. PubMed ID: 33076678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beneficial effects of inhibition of soluble epoxide hydrolase on glucose homeostasis and islet damage in a streptozotocin-induced diabetic mouse model.
    Chen L; Fan C; Zhang Y; Bakri M; Dong H; Morisseau C; Maddipati KR; Luo P; Wang CY; Hammock BD; Wang MH
    Prostaglandins Other Lipid Mediat; 2013; 104-105():42-8. PubMed ID: 23247129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of endotoxin-induced sarcoplasmic reticulum calcium leak improves mitochondrial and myocardial dysfunction.
    Hassoun SM; Marechal X; Montaigne D; Bouazza Y; Decoster B; Lancel S; Neviere R
    Crit Care Med; 2008 Sep; 36(9):2590-6. PubMed ID: 18679108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of haem oxygenase in the renoprotective effects of soluble epoxide hydrolase inhibition in diabetic spontaneously hypertensive rats.
    Elmarakby AA; Faulkner J; Pye C; Rouch K; Alhashim A; Maddipati KR; Baban B
    Clin Sci (Lond); 2013 Oct; 125(7):349-59. PubMed ID: 23611540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble epoxide hydrolase: a new target for cardioprotection.
    Gross GJ; Nithipatikom K
    Curr Opin Investig Drugs; 2009 Mar; 10(3):253-8. PubMed ID: 19333883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substituted adamantyl-urea inhibitors of the soluble epoxide hydrolase dilate mesenteric resistance vessels.
    Olearczyk JJ; Field MB; Kim IH; Morisseau C; Hammock BD; Imig JD
    J Pharmacol Exp Ther; 2006 Sep; 318(3):1307-14. PubMed ID: 16772540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Cytochrome p450 and Soluble Epoxide Hydrolase Enzymes and Their Associated Metabolites in the Pathogenesis of Diabetic Cardiomyopathy.
    Maayah ZH; McGinn E; Al Batran R; Gopal K; Ussher JR; El-Kadi AOS
    J Cardiovasc Pharmacol; 2019 Sep; 74(3):235-245. PubMed ID: 31306370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of SERCA isoform with faster Ca2+ transport properties improves postischemic cardiac function and Ca2+ handling and decreases myocardial infarction.
    Talukder MA; Kalyanasundaram A; Zhao X; Zuo L; Bhupathy P; Babu GJ; Cardounel AJ; Periasamy M; Zweier JL
    Am J Physiol Heart Circ Physiol; 2007 Oct; 293(4):H2418-28. PubMed ID: 17630344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of Soluble Epoxide Hydrolase Enzyme on Daunorubicin-Mediated Cardiotoxicity.
    Maayah ZH; Abdelhamid G; Elshenawy OH; El-Sherbeni AA; Althurwi HN; McGinn E; Dawood D; Alammari AH; El-Kadi AOS
    Cardiovasc Toxicol; 2018 Jun; 18(3):268-283. PubMed ID: 29196978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Symmetric adamantyl-diureas as soluble epoxide hydrolase inhibitors.
    Burmistrov V; Morisseau C; Lee KS; Shihadih DS; Harris TR; Butov GM; Hammock BD
    Bioorg Med Chem Lett; 2014 May; 24(9):2193-7. PubMed ID: 24685540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meloxicam fails to augment the reno-protective effects of soluble epoxide hydrolase inhibition in streptozotocin-induced diabetic rats via increased 20-HETE levels.
    Katary MM; Pye C; Elmarakby AA
    Prostaglandins Other Lipid Mediat; 2017 Sep; 132():3-11. PubMed ID: 27596333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble epoxide hydrolase: a novel therapeutic target in stroke.
    Zhang W; Koerner IP; Noppens R; Grafe M; Tsai HJ; Morisseau C; Luria A; Hammock BD; Falck JR; Alkayed NJ
    J Cereb Blood Flow Metab; 2007 Dec; 27(12):1931-40. PubMed ID: 17440491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of soluble epoxide hydrolase inhibition on early kidney damage in hyperglycemic overweight mice.
    Roche C; Guerrot D; Harouki N; Duflot T; Besnier M; Rémy-Jouet I; Renet S; Dumesnil A; Lejeune A; Morisseau C; Richard V; Bellien J
    Prostaglandins Other Lipid Mediat; 2015 Jul; 120():148-54. PubMed ID: 26022136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble epoxide hydrolase is involved in the development of atherosclerosis and arterial neointima formation by regulating smooth muscle cell migration.
    Wang Q; Huo L; He J; Ding W; Su H; Tian D; Welch C; Hammock BD; Ai D; Zhu Y
    Am J Physiol Heart Circ Physiol; 2015 Dec; 309(11):H1894-903. PubMed ID: 26453326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic treatment with insulin-like growth factor I enhances myocyte contraction by upregulation of Akt-SERCA2a signaling pathway.
    Kim SJ; Abdellatif M; Koul S; Crystal GJ
    Am J Physiol Heart Circ Physiol; 2008 Jul; 295(1):H130-5. PubMed ID: 18456736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.